Flatiron Health
Oncology technology and data company with real-world evidence, Flatiron Assist clinical decision support, and software for cancer care.
About
Flatiron Health builds technology and real-world evidence for oncology. The platform serves clinicians, researchers, and regulators, with two main lines: real-world evidence services for drug development, and Flatiron Assist, a clinical decision support tool used in cancer care.
Founded in 2012. An independent affiliate of the Roche Group since 2018, with subsidiaries in Japan, Germany, and the United Kingdom. Customers and partners include Takeda Oncology, Hematology Oncology Associates of Central New York, the FDA, the NIH, and AmerisourceBergen.
The data backbone is over 5 million de-identified patient records available for research. Stated mission is reimagining the infrastructure of cancer care.